{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T06:02:07Z","timestamp":1778133727136,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.joms.2006.02.011","type":"journal-article","created":{"date-parts":[[2006,5,20]],"date-time":"2006-05-20T07:22:30Z","timestamp":1148109750000},"page":"917-923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Bisphosphonates Are Associated With Increased Risk for Jaw Surgery in Medical Claims Data: Is it Osteonecrosis?"],"prefix":"10.1016","volume":"64","author":[{"given":"Athanasios I.","family":"Zavras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"supp1","key":"10.1016\/j.joms.2006.02.011_bib1","doi-asserted-by":"crossref","first-page":"10a","DOI":"10.1007\/BF02065192","article-title":"The influence of pyrophosphate analogues (diphosphonates) on the precipitation and dissolution","volume":"10","author":"Fleisch","year":"1968","journal-title":"Calcif Tissue Res"},{"key":"10.1016\/j.joms.2006.02.011_bib2","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1359\/jbmr.2003.18.11.2016","article-title":"Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young wistar rats","volume":"18","author":"Little","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2006.02.011_bib3","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1172\/JCI114100","article-title":"Inhibition of osteoclast-like cell formation by bisphosphonates in long term cultures of human bone marrow","volume":"83","author":"Hughes","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.joms.2006.02.011_bib4","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1172\/JCI116422","article-title":"Bisphosphonates act on rat bone resorption through the mediation of osteoblasts","volume":"91","author":"Sahni","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.joms.2006.02.011_bib5","unstructured":"Brixen K: Bisphosphonates as a potential treatment for osteogenesis imperfecta. Proceedings of the OIFE meeting, September 25-26, 1998. Vingsted, Denmark. Available at: www.brandx.net\/markgash\/bispho.html. Accessed February 24, 2006"},{"key":"10.1016\/j.joms.2006.02.011_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2474-3-19","article-title":"Systemic alendronate prevents resorption of necrotic bone revascularization. A bone chamber study in rats","volume":"3","author":"Astrand","year":"2002","journal-title":"BMC Musculoskelet Disord"},{"issue":"suppl 2","key":"10.1016\/j.joms.2006.02.011_bib7","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.3816\/CBC.2005.s.005","article-title":"Evolving role of bisphosphonates in women undergoing treatment for localized and advanced breast cancer","volume":"5","author":"Gralow","year":"2005","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.joms.2006.02.011_bib8","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years\u2019 experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2006.02.011_bib9","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2006.02.011_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2006.02.011_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.amjmed.2004.04.015","article-title":"Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma","volume":"117","author":"Lugassy","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.joms.2006.02.011_bib12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0714.2004.00269.x","article-title":"Avascular jaw osteonecrosis in association with cancer chemotherapy","volume":"34","author":"Bagan","year":"2005","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.joms.2006.02.011_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","article-title":"Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone","volume":"104","author":"Migliorati","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.joms.2006.02.011_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10006-005-0616-6","article-title":"Bisphosphonates and osteonecrosis of the jaw","volume":"9","author":"Schirmer","year":"2005","journal-title":"Mund Kiefer Gesichtschir"},{"key":"10.1016\/j.joms.2006.02.011_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Durie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2006.02.011_bib16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.joms.2004.03.005","article-title":"Osteonecrosis and bisphosphonates","volume":"62","author":"Schwartz","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2006.02.011_bib17","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.joms.2005.01.010","article-title":"Bisphosphonate osteochemonecrosis (bis-phossy jaw)","volume":"63","author":"Hellstein","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2006.02.011_bib18","first-page":"100","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Woo","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2006.02.011_bib19","first-page":"100","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Maerevoet","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2006.02.011_bib20","first-page":"111","article-title":"Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy","volume":"71","author":"Melo","year":"2005","journal-title":"J Can Dent Assoc"},{"key":"10.1016\/j.joms.2006.02.011_bib21","unstructured":"Pamer C, McCloskey C: Postmarketing safety assessment of osteonecrosis of the jaw. Pamidronate and zoledronic acid. Available at: www.fda.gov\/ohrms\/dockets\/ac\/05\/slides\/2005-4095S2_03_02-FDA-Pamer.ppt. Accessed April 7, 2005"},{"key":"10.1016\/j.joms.2006.02.011_bib22","unstructured":"Summary of ONJ cases from retrospective chart review at MD Anderson Cancer Center. Novartis Pharmaceutical Corporation. Available at: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/05\/briefing\/2005-4095B2_02_07-Novartis-Zometa-App6.pdf\u00b1onj&restrict=&site=FDA&output=xml_no_dtd&client=FDA&access=p&lr=&proxystylesheet=FDA&oe=. Accessed April 7, 2005"},{"key":"10.1016\/j.joms.2006.02.011_bib23","unstructured":"Drug linked to death of jawbone. USA Today. March 13, 2005. Available at: http:\/\/www.usatoday.com\/news\/health\/2005-03-13-jawbone-deaths_x.htm#. Accessed April 6, 2005"},{"key":"10.1016\/j.joms.2006.02.011_bib24","first-page":"6538","article-title":"Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats","volume":"62","author":"Fournier","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.joms.2006.02.011_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJMoa023110","article-title":"Bisphosphonate-induced osteopetrosis","volume":"349","author":"Whyte","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027823910600231X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027823910600231X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:18:17Z","timestamp":1759508297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027823910600231X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S027823910600231X"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2006.02.011","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bisphosphonates Are Associated With Increased Risk for Jaw Surgery in Medical Claims Data: Is it Osteonecrosis?","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2006.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}